H.C. Wainwright & Co. is acting as exclusive placement agent in connection with this offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INDP:
- Indaptus Therapeutics files $200M mixed securities shelf
- Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
- Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
- Indaptus Therapeutics Secures Approval for Private Placement
- Indaptus Regains Nasdaq Compliance with Bid Price